|
|
|
INFLUENZA VACCINE RETURN INSTRUCTIONS
|
|
 |
|
Generate Your Return Goods Form
|
| • |
Log on to VaccineShoppe.com |
| • |
Go to the Influenza Vaccine tab |
| • |
Click on Generate Returns Form |
| • |
Follow the instructions to generate your Return Goods Form |
| • |
Save and print the PDFs |
|
|
 |
|
Upload Return Goods Form & Generate Return Authorization
|
|
|
 |
|
Obtain Shipping Label & Send
|
| • |
Obtain a shipping label from your carrier (FedEx or UPS preferred) |
| • |
Secure the label on the outside of the box (do not cover the Return Authorization) |
| • |
|
|
|
|
All reservations are subject to Sanofi Pasteur's Terms and Conditions of Sale, including credit review, in effect at the time of reservation confirmation. Copies of which are available upon request or by logging on to VaccineShoppe.com.
|
|
If you have questions, please visit our website at www.VaccineShoppe.com or call 1-800-VACCINE (1-800-822-2463).
|
|
Fluzone Quadrivalent, Flublok Quadrivalent, and Fluzone High-Dose Quadrivalent are vaccines indicated for active immunization against disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. Fluzone Quadrivalent is approved for use in persons 6 months of age and older. Flublok Quadrivalent is approved for use in persons 18 years of age and older. Fluzone High-Dose Quadrivalent is approved for use in persons 65 years of age and older.
|
|
IMPORTANT SAFETY INFORMATION FOR FLUZONE QUADRIVALENT (INFLUENZA VACCINE), FLUBLOK QUADRIVALENT (INFLUENZA VACCINE), AND FLUZONE HIGH-DOSE QUADRIVALENT (INFLUENZA VACCINE)
|
|
Fluzone Quadrivalent, Flublok Quadrivalent, and Fluzone High-Dose Quadrivalent should not be administered to anyone who has had a severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine (including egg protein for Fluzone Quadrivalent and Fluzone High-Dose Quadrivalent) or after previous dose of the respective vaccine. In addition, Fluzone Quadrivalent and Fluzone High-Dose Quadrivalent should not be administered to anyone who has had a severe allergic reaction after previous dose of any influenza vaccine.
|
|
Appropriate medical treatment and supervision must be available to manage possible anaphylactic reactions following administration of the vaccine.
|
|
If Guillain-Barré syndrome has occurred within 6 weeks following previous influenza vaccination, the decision to give Fluzone Quadrivalent, Flublok Quadrivalent, and Fluzone High-Dose Quadrivalent should be based on careful consideration of the potential benefits and risks.
|
|
If Fluzone Quadrivalent, Flublok Quadrivalent, and Fluzone High-Dose Quadrivalent are administered to immunocompromised persons, including those receiving immunosuppressive therapy, the immune response may be lower than expected.
|
|
Vaccination with Fluzone Quadrivalent, Flublok Quadrivalent, and Fluzone High-Dose Quadrivalent may not protect all recipients.
|
|
For Fluzone Quadrivalent, in children 6 months through 35 months of age, the most common injection-site reactions were pain or tenderness, erythema, and swelling; the most common solicited systemic adverse reactions were irritability, abnormal crying, malaise, drowsiness, appetite loss, myalgia, vomiting, and fever. In children 3 years through 8 years of age, the most common injection-site reactions were pain, erythema, and swelling; the most common solicited systemic adverse reactions were myalgia, malaise, and headache. In adults 18 years and older, the most common injection-site reaction was pain; the most common solicited systemic adverse reactions were myalgia, headache, and malaise.
|
|
For Flublok Quadrivalent, in adults 18 through 49 years of age, the most common injection-site reactions were tenderness and pain; the most common solicited systemic adverse reactions were headache, fatigue, myalgia, and arthralgia. In adults 50 years of age and older, the most common injection-site reactions were tenderness and pain; the most common solicited systemic adverse reactions were headache, and fatigue.
|
|
For Fluzone High-Dose Quadrivalent, in adults 65 years of age and older, the most common injection-site reaction was pain; the most common solicited systemic adverse reactions were myalgia, headache, and malaise.
|
|
For Fluzone Quadrivalent, Flublok Quadrivalent, and Fluzone High-Dose Quadrivalent, other adverse reactions may occur.
|
Should you have any questions,
please contact your Sanofi Pasteur representative
or call 1-800-VACCINE (1-800-822-2463).
|
|
|
|
Please do not reply to this message. Replies to this message are routed to an unmonitored mailbox.
|
|
If you have questions, please visit Customer Support at VaccineShoppe.com® or call 1-800-VACCINE (1-800-822-2463).
|
|
Colorado Prescribers may click here for Wholesale Acquisition Cost Price Disclosure Information.
|
|
To be removed from our mailing list, please click here.
|
|
©2020 Sanofi Pasteur Inc.
|
|
|
|
